Key result
The Chinese version of the Arthritis Self-Efficacy Scale demonstrated acceptable internal consistency (Cronbach α 0.91) and test-retest reliability (ICC 0.89) in adults with rheumatic diseases.
Why the study?
Although the original English Arthritis Self-Efficacy Scale has shown high reliability and validity, a Chinese version had not yet been validated.
Is the Chinese version of the Arthritis Self-Efficacy Scale (C-ASES) a reliable and valid instrument for assessing self-efficacy in Chinese adults with rheumatic diseases?
Cross-Sectional (n=258)
No
Is the Chinese version of the Arthritis Self-Efficacy Scale (C-ASES) a reliable and valid instrument for assessing self-efficacy in Chinese adults with rheumatic diseases?
Effect estimate: Cronbach α 0.91, ICC 0.89
The Chinese version of the Arthritis Self-Efficacy Scale is a reliable and valid screening instrument for assessing self-efficacy in Chinese-speaking patients with rheumatic diseases.
May support C-ASES screening to guide self-efficacy interventions in Chinese RD patients; extends ASES validation but leaves open wider generalizability.
OBJECTIVE: The Arthritis Self-Efficacy Scale (ASES) was designed to assess the degree of self-efficacy among patients with arthritis. Though the original English version of this instrument has shown a high degree of reliability and validity, a Chinese version of this scale has yet to be validated. Therefore, the aim of this cross-sectional study was to evaluate the psychometric characteristics of the Chinese version of ASES (C-ASES) in a population of Chinese adults with rheumatic diseases (RDs). METHODS: After completing backward translation and expert validity, a convenient sample of 258 qualified participants with RDs from a hospital in Taiwan were recruited to explore the content validity, concurrent validity, construct validity, internal consistency reliability and test-retest reliability of C-ASES. RESULTS: The C-ASES has demonstrated acceptable internal consistency and test-retest reliability, with a Cronbach α of 0.91 and intraclass correlation coefficient of 0.89, respectively. Concurrent validity was acceptable, with significant correlation between the subscales of the C-ASES and perceived depressive symptoms, as measured by the Taiwanese Depression Questionnaire (p<0.05). The exploratory factor analysis revealed a three-factor solution (physical function, experienced pain and other symptoms) corresponding to the structure of the original instrument, which accounted for 59.78% of the total variance. CONCLUSION: Empirical data support the assertion that C-ASES is a reliable and valid screening instrument to assess self-efficacy in Chinese-speaking patients with RDs. C-ASES may be useful as a reference guide in providing appropriate interventions for bolstering self-efficacy among Chinese-speaking patients with RDs.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2021) conducted a cross-sectional in Rheumatic diseases (n=258). Chinese version of the Arthritis Self-Efficacy Scale (C-ASES) was evaluated on Internal consistency and test-retest reliability (Cronbach α 0.91, ICC 0.89). The Chinese version of the Arthritis Self-Efficacy Scale demonstrated acceptable internal consistency (Cronbach α 0.91) and test-retest reliability (ICC 0.89) in adults with rheumatic diseases.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: